Trexquant Investment »

Revance Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2023-12-31 $578k 66k 8.79
2023-03-31 $343k 11k 32.21
2022-12-31 $303k 16k 18.46
2022-03-31 $328k 17k 19.51
2018-06-30 $398k 15k 27.45
2018-03-31 $683k 22k 30.78
2017-12-31 $244k 6.8k 35.78
2017-06-30 $231k 8.8k 26.35
2016-03-31 $838k 48k 17.46
2015-12-31 $857k 25k 34.14
2015-09-30 $1.2M 40k 29.75
2015-06-30 $956k 30k 31.97
2015-03-31 $897k 43k 20.72
2014-12-31 $301k 18k 16.91